About us

Zora started its operations in 2007 with seed funding from three investors. Today Zora is running projects for pharmaceutical partners, academic researchers and is generating biomarkers and targets for commercialization.

The international Zora personnel has a strong background in pharmaceutical research and development, mass spectrometry, and lipid biochemistry. This expertise gained through several years of both academic and industrial work confers a competitive advantage on Zora.